发明名称 PH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
摘要 PROBLEM TO BE SOLVED: To provide an aerosolizable formulation comprising a drug, a carrier and pH affecting component.SOLUTION: The drug is dissolved in the formulation at a concentration above which it remains in solution at neutral pH. This increases the concentration of the drug in solution making it possible to administer larger amounts of drug with the same or a smaller volume of formulation. When the formulation is aerosolized to small particles and inhaled into human lungs in small volumes (e.g. 0.05 to 0.5 mL), the fluids in the lungs neutralize the formulation and the drug precipitates out of the solution. As a result, the drug is delivered at a controlled rate below the rate at which drug is administered from a formulation initially at a neutral pH. The drug is gallium nitrate, preferably a gallium salt. The pH effecting agent deviates formulation pH by 0.75 to 4.15 log units, particularly preferably by 1.0 to 2.01 log units or more away from 7.4.SELECTED DRAWING: None
申请公布号 JP2016164183(A) 申请公布日期 2016.09.08
申请号 JP20160081064 申请日期 2016.04.14
申请人 ARADIGM CORP 发明人 DAVID C CIPOLLA;IGOR GONDA
分类号 A61K9/72;A61K31/43;A61K31/47;A61K31/496;A61K31/545;A61K31/65;A61K33/24;A61P7/00;A61P31/04 主分类号 A61K9/72
代理机构 代理人
主权项
地址